The US Food and Drug Administration has approved the use of finerenone (Kerendia) in heart failure (HF) patients with mildly ...

Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...

Doctors are regularly overlooking a common hormone-driven cause of high blood pressure -- primary aldosteronism -- ...

Just like any other profession, even healthcare professionals can often make mistakes like missing symptoms or misdiagnosing ...

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

The study revealed that people with these genetic changes were found to be more than twice as likely to develop heart failure ...

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

Aldosterone helps balance blood levels of sodium and potassium, researchers said. Levels that are too high can cause people ...

Low magnesium is linked to issues like high cholesterol, type 2 diabetes, and heart disease. Getting enough magnesium through ...